FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080695 [Registered on: 17/02/2025] Trial Registered Prospectively
Last Modified On: 16/01/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A research to study the bone formation capacity of dentin taken from an extracted natural tooth and mixed with a blood cell concentrate.  
Scientific Title of Study   Use of autologous partially demineralized dentinal matrix (PDDM) with novel injectable platelet-rich fibrin (i-PRF) for bone grafting after impacted mandibular third molar surgery– A randomized clinical trial.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S K Jagdish 
Designation  Professor 
Affiliation  Chettinad Dental College and Research Institute 
Address  Department of Prosthodontics, E-Block, Room No.7, 3rd Floor, Chettinad Dental College and Research Institute, Rajiv Gandhi Salai, Kelambakkam

Kancheepuram
TAMIL NADU
603103
India 
Phone  9940163850  
Fax    
Email  jagdishsk@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S K Jagdish 
Designation  Professor 
Affiliation  Chettinad Dental College and Research Institute 
Address  Department of Prosthodontics, E-Block, Room No.7, 3rd Floor, Chettinad Dental College and Research Institute, Rajiv Gandhi Salai, Kelambakkam

Kancheepuram
TAMIL NADU
603103
India 
Phone  9940163850  
Fax    
Email  jagdishsk@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S K Jagdish 
Designation  Professor 
Affiliation  Chettinad Dental College and Research Institute 
Address  Department of Prosthodontics, E-Block, Room No.7, 3rd Floor, Chettinad Dental College and Research Institute, Rajiv Gandhi Salai, Kelambakkam

Kancheepuram
TAMIL NADU
603103
India 
Phone  9940163850  
Fax    
Email  jagdishsk@gmail.com  
 
Source of Monetary or Material Support  
Chettinad Dental College and Research Institute, Department of Prosthodontics and Department of Oral Surgery, Rajiv Gandhi Salai, Kelambakkam, Kancheepuram District, Pin - 603103. 
 
Primary Sponsor  
Name  Dr S K Jagdish 
Address  Department of Prosthodontics, Chettinad Dental College and Research Institute, E-Block, 3rd Floor, Room No. 7, Rajiv Gandhi Salai, Kelambakkam, Pin - 603103 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S K Jagdish  Chettinad Dental College and Research Institute  Department of Prosthodontics and Implantology, Chettinad Dental College and Research Institute, E-Block, 3rd Floor, Room No.7, Rajiv Gandhi Salai, Kelambakkam
Kancheepuram
TAMIL NADU 
9940163850

jagdishsk@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee Chettinad Dental College and Research Institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K011||Impacted teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Extraction of mandibular 3rd molar tooth followed by grafting with PDDM mixed with novel i-PRF graft material.  Oral prophylaxis will be done and patients will be prescribed 0.2% chlorhexidine mouthwash before tooth removal. Surgical removal of the tooth will be done by an experienced Oral and Maxillofacial Surgeon under local anesthesia (2% Lignocaine with adrenaline). A baseline intra-oral periapical radiograph (IOPA) will be taken immediately after tooth extraction using a standardized technique and exposure. To prepare the PDDM, all the soft tissues on the extracted tooth will be cleaned using a scaler. Caries/restorations will be removed using a high seed airotor with water. After airdrying the tooth will be ground into small particles using a grinder or bone mill. The particles will be demineralized using 0.6 N HCl for 30 minutes and washed with buffered saline (pH 7.0) three to four times. To prepare the novel i-PRF, 10 ml of venous blood will be collected from the cubital vein of the patient in a silica-coated vacutainer tube and centrifuged at 2000 g for 3 minutes. The i-PRF layer along with the buffy coat will be aspirated and mixed the prepared PDDM graft and allowed to clot The sockets in the test group will grafted with PDDM+ novel i-PRF graft followed by primary closure. All patients will be scheduled for follow-up visits on the 3rd day, 14th day, and 3 months. Postoperative radiographs will be obtained at 3 months. 
Comparator Agent  Extraction of mandibular 3rd molar tooth followed by no grafting.  Oral prophylaxis will be done and patients will be prescribed 0.2% chlorhexidine mouthwash before tooth removal. Surgical removal of the tooth will be done by an experienced Oral and Maxillofacial Surgeon under local anesthesia (2% Lignocaine with adrenaline). A baseline intra-oral periapical radiograph (IOPA) will be taken immediately after tooth extraction using a standardized technique and exposure. The sockets in the comparator group will not receive any graft material. The site will be cleaned and irrigated followed by primary closure. All patients will be scheduled for follow-up visits on the 3rd day, 14th day, and 3 months. Postoperative radiographs will be obtained at 3 months. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1. Patients with impacted mandibular 3rd molar indicated for extraction.
2. Impacted - vertical, horizontal, or mesioangular with mild to moderate difficulty (Pederson Classification).
3. Teeth with minimal caries / minimally restored
4. Patients with adequate mouth opening preoperatively.
5. Patients willing to come for follow-up visits.
 
 
ExclusionCriteria 
Details  1. Impacted teeth that are grossly decayed / severe loss of tooth structure.
2. Complicated extraction – curved roots, fracture of the bone, or excessive intraoperative hemorrhage.
3. Patients with smoking/tobacco use.
4. Uncontrolled systemic diseases/bone/ bleeding disorders.
5. Patients with abscesses or periapical lesions.
6. History of allergy to any drugs/biomaterials.
7. Patients with a history of radiotherapy/chemotherapy.
8. Using drugs that may affect bone metabolism and healing (eg. Bisphosphonates, steroids etc.,)
9. Pregnant and lactating women / contraceptive use.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To measure the relative bone density in the surgical site   At baseline (immediately after tooth removal) and at 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Evaluation of post-operative pain, swelling, mouth opening  Baseline (before extraction), 3rd day and 14th day 
Graft loss/rejection and infection   Baseline to 3 months 
Radiographic bone healing using   At baseline (immediately after tooth removal) and at 3 months 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "20"
Final Enrollment numbers achieved (India)="20" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [jagdishsk@gmail.com].

  6. For how long will this data be available start date provided 01-01-2026 and end date provided 01-01-2028?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  

Aims and Objectives:

This study aims to assess the bone regeneration potential of PDDM + novel i-PRF when used in 3rd molar extraction sites. .

Material and Methods:

Ethical approval will be obtained before the study is stated. All the procedures will be done in adherence with the Declaration of Helsinki. Informed and written consent will be obtained from all the patients who are willing to participate. The CONSORT guidelines will be followed for reporting the study. 

The study will be conducted as a randomized trial with two parallel arms. All the patients will be randomly assigned to either the test (PDDM +i-PRF) group or the control (no graft) group. Before the surgery, oral prophylaxis will be done and patients will be prescribed 0.2% chlorhexidine mouthwash. Surgical removal of the tooth will be done by an experienced Oral and Maxillofacial Surgeon under local anesthesia (2% Lignocaine with adrenaline).  A baseline intra-oral periapical radiograph (IOPA) will be taken immediately after tooth extraction using a standardized technique and exposure.

To prepare the PDDM, all the soft tissues on the extracted tooth will be cleaned using a scaler. Caries/restorations will be removed using a high seed airotor with water. After airdrying the tooth will be ground into small particles using a grinder or bone mill. The particles will be demineralized using 0.6 N Hcl for 30 minutes and washed with buffered saline (pH 7.0) three to four times.

To prepare the novel i-PRF, 10 ml of venous blood will be collected from the cubital vein of the patient in a silica-coated vacutainer tube and centrifuged at 2000 g for 3 minutes. The i-PRF layer along with the buffy coat will be aspirated and mixed the prepared PDDM graft and allowed to clot.

The sockets in the test group will not receive any graft material. The site will be cleaned and irrigated followed by primary closure. The sockets in the test group will grafted with PDDM+ novel i-PRF graft followed by primary closure.

Relative Bone Density measurement:
On 3-month recall visit, a postoperative IOPA will be made using the same exposure parameters as done at baseline. The pre and post-IOPA images will be analysed in an image analysis software (Image J) to measure the change in the grayscale as described in previous reports. The change in the relative bone density (grayscale value) from baseline and 3 months will be calculated.

All patients will be recalled for follow-up on the 3rd day and the 14th day. The suture removal will be done on the 14th day.

Assessment of Pain: (3rd and 14th day)

A 10-point Visual Analog scale (VAS) will be used for measuring the pain scores on the 3rd day and 14th day. A score of 0 indicates “No pain” and 10 indicates “severe pain”.

Facial swelling: (3rd and 14th day)

The extent of facial swelling will be assessed using the method proposed by Schultze-Mosgau et al.[8] Briefly, the distance between the tragus to the corner of the lip and the tragus to the pogonion will be measured. The average of these measurements will be made pre-operatively and during the follow-up, visits. The change in the measurements from the baseline and on 3rd day, and 14th day will be expressed as percentages. 

 

Mouth Opening: (3rd and 14th day)

The mouth opening will be measured as the maximum distance between the upper and lower incisors using a digital caliper. Trismus will be calculated as the difference in mouth opening at baseline and during follow-up visits and expressed as percentages.[8]


Graft loss/ rejection and postoperative infection:

All the patients will be followed for a period of 3 months. Any loss of the graft/ rejection or infection at the surgical site during the follow-up period will be noted.


Radiographic bone density and  healing :

The radiographic bone density will be measured using any image analysis software as greyscale values.

The pre and post-IOPA images will be analyzed for bone healing using the scale proposed by Kelly et al.


 
Close